Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease that significantly impacts the quality of life for both patients and their caregivers.
As a result, participating in a clinical trial, while possibly lifesaving, creates significant strain on top of everyday challenges.
We surveyed IPF patients and caregivers to better understand their needs for participating in a patient-centric clinical trial.
Read our article to learn more about how these factors affect protocol development for your upcoming IPF study.
